CogState (CGS.AX) Dionica Cijena
CogState Cijena
U posljednjih 19 godina prihod CogState rastao je 20,0 % godišnje i dosegnuo 53,09 mil. USD. Zarada po dionici rasla je 8,5 % godišnje u posljednjih 16 godina. Za CogState neto marža od 19,1 % je porasla u odnosu na 16,0 % prije nekoliko godina. Po današnjoj cijeni dividendni prinos iznosi otprilike 1,15 %. Omjer isplate je oko 34 % dobiti. Konsenzusna 12-mjesečna ciljana cijena za CogState je 2,11 USD, oko ispod tečaj za 15,2 %. Od 6 analitičara 5 preporučuje kupnju — ukupni konsenzus je Kupi.
Cijena dionice CogState
Pristupite ovim podacima putem Eulerpool API-ja
100.000 zahtjeva/mj. besplatno · bez kartice
Dioncia CogState i analiza dionice
Često postavljana pitanja o dionici CogState
CogState Ltd is a leading provider of cognitive testing services for clinical trials, academic research, and healthcare. The company's business model revolves around using their digital tools and technologies to measure and enhance cognitive function in patients. By collaborating with pharmaceutical companies, academic institutions, and healthcare organizations, CogState Ltd aims to improve patient outcomes and accelerate the development of new treatments. With their expertise and extensive database, CogState Ltd offers customized solutions and prognostic insights to address the cognitive challenges faced in various industries.
CogState Ltd is primarily active in the healthcare and pharmaceutical industries.
The main competitors of CogState Ltd in the market are Cambridge Cognition Holdings PLC, Neurotrack Technologies Inc., and CogniFit Ltd. These companies also specialize in cognitive assessment and provide similar solutions and services. However, CogState Ltd distinguishes itself through its innovative technologies and partnerships, including collaborations with leading pharmaceutical companies. With its strong focus on enhancing the understanding and measurement of cognitive function, CogState Ltd continues to remain competitive in the market and deliver valuable solutions to its clients.
CogState Ltd is a renowned company with a rich history and background. Founded in 1999, CogState specializes in cognitive testing and offers innovative solutions to improve brain health assessment. With its headquarters in Melbourne, Australia, the company has expanded its global presence, serving various sectors including pharmaceuticals, biotechnology, and academic research. CogState has developed cutting-edge technologies and software platforms to deliver accurate and efficient cognitive assessments, benefiting patients, researchers, and professionals worldwide. Known for its advanced cognitive testing methods and commitment to enhancing brain health, CogState Ltd has established itself as a trusted industry leader.
CogState Ltd has achieved several significant milestones in its history. One key achievement is the development and commercialization of its pioneering cognitive testing technology, known as the CogState Computerized Cognitive Assessment Tool (CCAT). This innovative tool is widely utilized in clinical trials and research studies worldwide, enabling precise and objective measurement of cognitive function. Additionally, CogState Ltd has successfully established strategic partnerships with leading pharmaceutical companies, academic institutions, and healthcare providers, facilitating the widespread adoption of its solutions. The company continues to thrive through ongoing research and development, further cementing its position as a global leader in cognitive assessment technology.
CogState Ltd is primarily present in Australia, the United States, and Europe.
CogState Ltd represents a set of core values and a corporate philosophy that drive its operations. The company is committed to innovation, delivering cutting-edge solutions in the fields of cognitive assessment and clinical trials. CogState prioritizes integrity, ensuring transparent and ethical practices in all aspects of its business. With a focus on collaboration, CogState fosters strong partnerships to drive mutual success. The company values dedication to excellence, constantly striving for improvement and delivering high-quality products and services. CogState fosters a customer-centric approach, prioritizing customer satisfaction and delivering tailored solutions. Overall, CogState Ltd embodies a commitment to innovation, integrity, collaboration, excellence, and customer-centricity in its corporate philosophy.
Analitičari trenutačno postavljaju prosječnu ciljanu cijenu 2,11 USD za dionicu CogState (medijan: 2,11 USD), što znači −18,3 % u odnosu na zadnju cijenu. Konsenzus se temelji na 6 ocjena.
7 analitičara trenutačno ocjenjuje dionicu CogState: 6 preporučuje kupnju, 1 držanje i 0 prodaju. Za 2026 analitičari očekuju da CogState ostvari prihod 128,65 mil. USD i zaradu po dionici 0,09 USD.
Po trenutačnom tečaju dionica CogState kotira 2,25 EUR (2,49 USD).
Dionica CogState (CGS.AX) uvrštena je na 2 burze, uključujući: ASX (CGS.AX).
CogState Ltd is an innovative company specializing in the development and marketing of cognitive testing solutions. The company offers a wide range of products and services that can be used in the fields of pharmaceutical research, clinical diagnostics, and sports performance optimization. The three main business divisions of CogState Ltd include research and development of cognitive tests, clinical diagnostics and monitoring of patients with neurodegenerative disorders, and solutions for improving sports performance. The company's products are rooted in today's technology, as they are exclusively offered online. They allow for remote diagnosis and supervision of patients, saving time for therapists and improving diagnostic accuracy. The company's proprietary software platform enables researchers to effectively manage their studies and present study results in a concise format. CogState Ltd has a strategy in place to continue offering unique and expanding product offerings, allowing the company to remain a strong competitor in the industry.
Prihod od očekivane od CogState iznosi 128,65 mil. USD. Ova brojka temelji se na trenutnim financijskim podacima i odražava poslovnu uspješnost poduzeća.
Dobit od očekivane od CogState iznosi 16,22 mil. USD. Neto dobit pokazuje profitabilnost poduzeća nakon odbitka svih troškova.
Omjer cijene i zarade (KGV) od CogState trenutno je 26,75. KGV uspoređuje trenutnu cijenu dionice sa zaradom po dionici i pomaže ulagačima da procijene vrednovanje dionice CogState.
Omjer cijene i prihoda (KUV) od CogState trenutno je 3,37. KUV uspoređuje tržišnu kapitalizaciju s godišnjim prihodom i služi kao pokazatelj vrednovanja dionice CogState.
Eulpool Quality Score za CogState je 8/10.
ISIN od CogState je AU000000CGS8. ISIN (International Securities Identification Number) je globalno jedinstvena identifikacija za vrijednosne papire.
Ticker od CogState je CGS.AX. Simbol tickera koristi se za trgovanje dionicama CogState na burzi.
CogState dionica
CogState Grupa usporediva
CogState Simbol
CogState FIGI
Sve temeljne informacije i detaljnu analizu CogState u detaljnom pregledu
Naša analiza dionica CogState uključuje važne financijske pokazatelje kao što su prihod, dobit, P/E omjer, P/S omjer, EBIT, kao i informacije o dividendi. Također, razmatramo aspekte poput dionica, tržišne kapitalizacije, dugova, vlastitog kapitala i obveza CogState. Ako tražite detaljnije informacije o ovim temama, na našim podstranicama nudimo opsežne analize: